WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2023

Aug 24, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2023-08-22

Reporting Person: Reiss-Clark Cindy (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-22	Common Stock	M	1112.00	$173.22	Acquired	5432.1611	Direct
2023-08-22	Common Stock	M	1588.00	$274.29	Acquired	7020.1611	Direct
2023-08-22	Common Stock	M	777.00	$369.13	Acquired	7797.1611	Direct
2023-08-22	Common Stock	S	3477.00	$393.34	Disposed	4320.1611	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-22	Stock Options (Right to buy)	$369.13	M	777.00	Disposed	2032-02-22	Common Stock (777.00)	Direct
2023-08-22	Stock Options (Right to buy)	$274.29	M	1588.00	Disposed	2031-02-23	Common Stock (1588.00)	Direct
2023-08-22	Stock Options (Right to buy)	$173.22	M	1112.00	Disposed	2030-02-18	Common Stock (1112.00)	Direct

Footnotes

F1: This award vests in four equal annual installments beginning on February 22, 2023.

F2: This award vests in four equal annual installments beginning on February 23, 2022.

F3: This award vests in four equal annual installments beginning on February 18, 2021.